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Abstract (200 words) 
Objectives: Clear communication of systematic review findings will help readers and decision 
makers. We built on previous work to develop an approach that improves the clarity of 
statements to convey findings and that draws on Grading of Recommendations Assessment, 
Development and Evaluation (GRADE). 
Study Design and Setting: We conducted workshops including 80 attendants and a survey of 
110 producers and users of systematic reviews. We calculated acceptability of statements and 
revised the wording of those that were unacceptable to ≥40% of participants.  
Results: Most participants agreed statements should be based on size of effect and certainty of 
evidence. Statements for low, moderate and high certainty evidence were acceptable to >60%. 
Key guidance, for example, includes statements for high, moderate and low certainty for a large 
effect on intervention x as: x results in a large reduction…; x likely results in a large reduction…; 
x may result in a large reduction…, respectively. 
Conclusions: Producers and users of systematic reviews found statements to communicate 
findings combining size and certainty of an effect acceptable. This article provides GRADE 
guidance and a wording template to formulate statements in systematic reviews and other 
decision tools. 
Keywords: review literature as topic, health communication, Evidence-Based Medicine, Surveys 
and Questionnaires, Language, persuasive communication  
Running title: Informative statements for systematic reviews 
Word count: 3582 (not including tables, boxes, figures or references)  
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What is new? 
Key findings 
- A set of statements to interpret results of systematic reviews of interventions and 
communicate them to patients, the public, and health care professionals was developed based 
on the GRADE approach to assess evidence. Experience with the statements and informal 
feedback showed that existing formulations were still not quite fit for purpose, and often used 
inconsistently. 
- Building on results of workshops and a survey including producers and users of systematic 
reviews we revised the standardized statements. 
- There was agreement that communicating the findings of reviews should be based on two 
components of a result: the magnitude or size of the effect and the certainty of the evidence.  
What this adds to what is known 
Inconsistent words and phrases have been used to communicate the results of systematic 
reviews to users. Our suggested standardized statements are informative and were found to be 
acceptable to producers and users of systematic reviews. We provide detailed guidance for how 
to use the statements. 
What is the implication, what should change now 
The template to formulate statements can be used to communicate the results of systematic 
reviews to users. These statements can be used in many sections of the systematic review, in 
evidence tables, and in tools or products for decision makers based on systematic reviews such 
as guideline recommendations. 
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1. Introduction 
Systematic reviews aim to synthesise evidence and provide readers with a summary of the 
findings for a specific intervention. To achieve this goal, the findings should be communicated 
as clearly and as simply as possible. The GRADE approach posits that there are two important 
components of a result of a review: the effect of the intervention, presented as the risk or 
difference in effect, as absolute numbers (e.g., 5 fewer deaths per 100), or as a narrative 
synthesis; and the certainty of (or confidence in) the evidence for that effect (categorised using 
the GRADE approach into high, moderate, low and very low) [1-6]. Both components should be 
conveyed to avoid misleading the reader. Consider, for example, a systematic review of the 
effects of waiving surgical fees to improve the use of cataract surgical services [7]. The authors 
found a risk ratio of 1.94 for the uptake of surgery, which they determined was an important 
increase in uptake. The certainty of evidence was low due to indirectness and imprecision (95% 
CI 1.14 to 3.31). If the authors conclude that there is an increase in uptake, but do not indicate 
that there is low certainty, readers could misinterpret the result as meaning that waiving 
surgical fees does increase uptake when in fact there is uncertainty. Although, the levels of 
evidence provided by the GRADE approach should be used to communicate the results (e.g., 
there is moderate certainty evidence that intervention A has X effect), various other phrases 
have been used, such as ‘limited evidence’, ‘insufficient evidence’, ‘no evidence to support’, or 
‘the evidence shows, at best, a modest, non-statistically significant trend in favour of 
intervention A’. All of which can confuse readers. Previous research has explored methods to 
best communicate results and the GRADE Working Group has developed Evidence profiles and 
Summary of Findings Tables [3, 8-10]. While these tables help readers understand the results of 
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systematic reviews, this research found that many participants also appreciated brief 
statements describing the results [11, 12].  
 
However, guidance for how to interpret and communicate results using statements is limited. 
The previous version of the Cochrane Handbook provided some guidance to not describe 
results as statistically or not statistically significant and avoid the common misinterpretation 
that large p values mean ‘no difference’ or ‘no effect’ or small p values mean an important 
effect [1, 8]. It also cautions authors about using ‘evidence of no effect’ or ‘no evidence of 
effect’ because these phrases are often used incorrectly. In 2010, we developed and tested four 
statements that were based on the size of an effect and the certainty of the evidence using the 
GRADE approach. Since then, we have received informal feedback suggesting that these 
statements are restrictive and other options are needed, and therefore we decided to improve 
and test new approaches.  
 
Our goal was to develop a set of standardized statements with multiple options for interpreting 
and communicating results of systematic reviews , and to write guidance. The statements 
assume that the evidence for an outcome is assessed using the GRADE approach or another 
formal system with four levels of evidence. It also assumes that certainty of evidence is not 
solely based on the imprecision of the result (i.e., power of the analysis and width of confidence 
interval), but also on other criteria, such as risk of bias of the studies, inconsistency 
(heterogeneity) of the result, indirectness (including subgroup analyses and applicability of the 
outcome measure), publication bias, and others. 
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2. Methods  
2.1. Summary of research methods 
The overall design is shown in Figure 1. 
 
Figure 1: Study design 
 
2.2. Preliminary development  
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In 2010, during research to create a summary to present results from a systematic review to 
consumers, we developed, tested, and received feedback from an advisory group of 
statisticians about, statements to describe the effect of an intervention on an outcome. Single 
statements combined words for the size of an effect on an outcome and the certainty in that 
effect [12]. For example, suppose a review found that vitamin D results in an important 
reduction in falls with moderate certainty. The size of the effect would be described as reduces, 
and probably would indicate the certainty , and the final statement would be - “vitamin D 
probably reduces falls”. Depending on the size/importance of the effect, different qualifiers 
were used: for an important reduction in an outcome, the verb used was reduces; to describe a 
less important effect slightly reduces was used; and when the effect was close to a null effect, 
little to no difference was used. A different qualifier was used to express certainty: high, 
moderate, low or very low certainty were conveyed as will, probably, may, and we are 
uncertain, respectively.  
 
During this research, we explored different approaches. Initially, we had six different ways to 
categorise the size of an effect based on how wide/narrow the confidence intervals were. 
However, the width is already considered in the GRADE assessment and therefore the number 
of categories was reduced to three: important, less important and little to no difference. We 
also explored different qualifiers based on why evidence was rated down. If the evidence was  
low certainty because it was rated down twice for imprecision the qualifier was we are very 
uncertain, but if the evidence was rated down twice - once for imprecision and once for risk of 
bias - the qualifier was possibly. This system was after more discussion reduced to the four 
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categories of GRADE because the level of certainty reflects our uncertainty regardless of what 
specific domains are rated down.    
 
2.3. Workshops 
Following publication of the minimum set of statements and years of informal feedback, a small 
working group of authors met and created a longer list of options. We conducted three 
workshops at GRADE meetings in 2016 and 2017, each with approximately 20 – 40 people with 
expertise in methods of systematic reviews and guideline development, some of whom did not 
speak English as a first language. During the workshops, participants reviewed 4-6 examples of 
the results for an outcome of a systematic review as forest plot of a meta-analysis (Figure 2), a 
narrative synthesis, or in absolute effects, along with the certainty of the evidence and 
explanations We asked participants to discuss what statements they would use to express the 
result or if they agreed with the statement provided and why. We used the feedback to make 
revisions to our list. 
Figure 2: Example of information provided to workshop participants for feedback 
Note: the appropriate statement in this example is ‘hip protectors probably reduces the risk of 
hip fractures slightly’ 
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2.4. Survey 
From March to April 2018, we conducted an electronic survey using SurveyMonkey to 
determine the acceptability of the statements (Appendix 1). We purposively invited by email: 1) 
people who conduct or summarise systematic reviews for use in decision making; 2) people 
who use systematic reviews; and 3) statisticians with systematic review experience. Members 
of the GRADE Working Group were also invited. Invited participants could forward the email to 
others and we sent one reminder one week later. The survey link was also sent via one author’s 
professional Twitter account (approximately 2000 followers). The first part of the survey asked 
participants about their roles in reviews and epidemiological training. Section 2 presented 
results for one outcome from five systematic reviews with 3 to 4 statements. Respondents 
rated the statements as unacceptable, acceptable or ideal. Section 3 asked ‘Do you agree in 
principle that conclusions should be based on the concepts of the importance/size of the effect 
and the certainty of the evidence?’. We piloted the survey in two people and revised 
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accordingly. The Hamilton Integrated Research Ethics Board waived formal ethics approval. One 
investigator analysed the data using descriptive statistics, and summarised the free-text 
comments by broad themes. A priori, we decided to revise statements that were ‘unacceptable’ 
to more than 40% and keep statements that more than 60% judged acceptable or ideal. 
 
2.5. Incorporation of results  
The lead authors incorporated the survey and workshop results into the statements and 
developed guidance. We presented the results to approximately 60 attendees at a GRADE 
Working Group meeting (April 2018) and to approximately 80 people in September 2018 (for 
approval.  
 
3. Results and Implications 
3.1 Acceptability of statements 
Of the 110 respondents (19 of whom were members of this GRADE project group), 72% 
described themselves as systematic review or guideline methodologists, and 13% as readers of 
reviews. Approximately, 30% indicated they had no formal education in epidemiology. Two did 
not answer all questions; however, their results were included. In section 2, 39 provided 
written comments about acceptability, and 15 provided comments in section 3. We present 
results from the 91 participants and use the comments of the project members to contextualise 
results (see Appendix 2 for raw data from survey). We did not calculate a response rate since 
participants could forward the link to others. The final list of informative statements is in Table 
1. 
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Acceptability of statements for very low certainty evidence: The statement “[Intervention X] 
may reduce the [outcome] slightly but we are uncertain” was presented in two examples and 
was rated as unacceptable by 37% in one example and 46% in the other. The comments 
highlighted that we are uncertain could be misinterpreted; respondents suggested that it would 
be clearer to instead write that the evidence is uncertain. The two examples also provided two 
statements stating the direction of effect: “We are uncertain about whether co-enzyme Q10 
reduces blood pressure” – acceptable to 80%, and “We are uncertain about the effect of co-
enzyme Q10 on blood pressure” – acceptable to 71%. During workshops, there was also some 
debate about communicating a direction of effect when the evidence is so uncertain. However, 
we have kept both options for very low certainty: uncertain effect with or without a direction of 
effect. 
 
Acceptability of statements for low certainty evidence: Participants were presented with the 
qualifying words may, appears, suggests, and likely (“Probiotics may result in a large reduction 
in the incidence of diarrhea). Likely was rated as unacceptable by 52%; appears by 50%, and 
suggests by 57%. Respondents observed that most words to convey low certainty evidence 
were vague e.g., may could be interpreted may or may not. Respondents wrote that suggests 
could be more acceptable, and some noted that appears sounded supernatural. Therefore, 
appears was deleted, but may and suggests remain options for low certainty evidence. 
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Acceptability of statements for moderate certainty and high certainty evidence: There were few 
comments and both likely and probably were acceptable. 
 
Acceptability of statements to communicate size of effect: In one example, the intervention 
resulted in 2 more hip fractures per 1000 (from 2 fewer to 6 more) and the authors judged that 
2 more did not reach a threshold for an effect either as a beneficial reduction or as a harm. Two 
of the example narrative statements used results in little to no difference and the other two 
used does not reduce outcome. Little to no difference was unacceptable to 20%, and does not 
reduce to 35-40%. There were many comments that does not should not be used when 
communicating a result close to null effect. Workshop participants also often expressed 
concern with interpreting null effect as does not affect.  
 
Another example explored the acceptability of statements to convey evidence for a small effect 
that is not important. Two of the three statements describing the effect as a small possible 
unimportant reduction were rated as unacceptable by 45 to 50%. Participants responded that 
the high number of qualifying words could be confusing. Statements with multiple qualifiers for 
importance were therefore deleted and a small effect has been divided into a small and 
important effect and an unimportant effect as trivial or small, unimportant or no effect (‘trivial’ 
is added to be consistent with GRADE’s Evidence to Decision frameworks [13-17]). In this 
example, do not result in was used and again there were comments that it is not correct to 
describe a result near the null effect as not occurring. The words do not or does not to describe 
little to no effect are still an option. 
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3.2 Agreement about principles of size of effect and certainty of evidence 
Ninety-nine percent (84/85) agreed that statements should be based on both size of the effect 
and certainty of evidence. In general, respondents were concerned that it is difficult to 
determine whether an effect is large, moderate, small (important or not important), or of little 
to no effect. Comments also highlighted to not interpret wide confidence intervals and non-
statistically significant results as no effect. 
 
Table 1: Final list of informative statements to communicate results of systematic reviews 
Size of the effect 
estimate 
Suggested statements  
(replace X with intervention, replace ‘reduce/increase’ with direction of 
effect, replace ‘outcome’ with name of outcome, include ‘when compared 
with Y’ when needed) 
HIGH Certainty of the evidence 
Large effect X results in a large reduction/increase in outcome 
Moderate effect 
X reduces/increases outcome 
X results in a reduction/increase in outcome 
Small important 
effect 
X reduces/increases outcome slightly 
X results in a slight reduction/increase in outcome 
Trivial, small 
unimportant effect 
or no effect 
X results in little to no difference in outcome  
X does not reduce/increase outcome 
MODERATE Certainty of the evidence 
Large effect 
X likely results in a large reduction/increase in outcome 
X probably results in a large reduction/increase in outcome 
Moderate effect 
X likely reduces/increases outcome 
X probably reduces/increases outcome 
X likely results in a reduction/increase in outcome 
X probably results in a reduction/increase in outcome 
Small important 
effect 
X probably reduces/increases outcome slightly 
X likely reduces/increases outcome slightly 
X probably results in a slight reduction/increase in outcome 
X likely results in a slight reduction/increase in outcome 
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Trivial, small 
unimportant effect 
or no effect 
X likely results in little to no difference in outcome 
X probably results in little to no difference in outcome 
X likely does not reduce/increase outcome 
X probably does not reduce/increase outcome 
LOW Certainty of the evidence 
Large effect 
X may result in a large reduction/increase in outcome 
The evidence suggests X results in a large reduction/increase in outcome 
Moderate effect 
X may reduce/increase outcome 
The evidence suggests X reduces/increases outcome 
X may result in a reduction/increase in outcome 
The evidence suggests X results in a reduction/increase in outcome 
Small important 
effect 
X may reduce/increase outcome slightly 
The evidence suggests X reduces/increases outcome slightly 
X may result in a slight reduction/increase in outcome 
The evidence suggests X results in a slight reduction/increase in outcome 
Trivial, small 
unimportant effect 
or no effect 
X may result in little to no difference in outcome 
The evidence suggests that X results in little to no difference in outcome  
X may not reduce/increase outcome  
The evidence suggests that X does not reduce/increase outcome 
VERY LOW Certainty of the evidence 
Any effect 
The evidence is very uncertain about the effect of X on outcome  
X may reduce/increase/have little to no effect on outcome but the 
evidence is very uncertain  
 
4. Discussion and Guidance 
4.1. Discussion 
We have created a list of brief and informative statements that authors of systematic reviews, 
and people presenting evidence to decision makers, e.g., guideline developers, can use to 
describe the results (Table 1). This work builds on our previous research, on many years of 
experience using the statements, a survey, and on feedback received during GRADE working 
group meetings. Although we piloted examples and the survey, there is still the potential that 
we may not have expressed the task clearly to respondents, resulting in some confusion. 
However, we received comments from a variety of important stakeholders, including 
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methodologists in systematic reviews and guidelines and readers, and found results were 
consistent. We provide guidance to use these statements, and examples in Appendix 3. 
 
4.2. Use of certainty of evidence and size of effect to write informative statements 
The basic premise is that review authors should report both the effect of an intervention on an 
outcome and the certainty in the evidence. Authors can communicate these components in 
multiple ways. GRADE guidance now suggests two approaches. First, authors may communicate 
the findings by providing the effect on the outcome and the certainty of the evidence according 
to the GRADE levels of evidence (i.e., provide the point estimate and confidence interval in 
relative and absolute terms, and then specify that the evidence is "moderate certainty").  
Second, if authors want to communicate the result in one statement, they should use Table 1, 
first selecting the category for certainty of evidence, then making a judgement regarding the 
size of the effect, and finally choosing from the appropriate wording options (e.g., for a small 
important effect of moderate certainty - "intervention A likely increases outcome X slightly”).”  
 
4.3. Decisions about the size of the effect 
To create a statement using Table 1, authors must decide into which category the size of effect 
falls. The GRADE Evidence to Decision framework provides some guidance about the size of 
effect [13-17]. However, when conducting a GRADE assessment, in particular when assessing 
imprecision, systematic reviewers partially contextualise decisions using thresholds for no or 
trivial, small, moderate and large effects [18-21]. These decisions can be based on research into 
minimal important differences, discussions within the systematic review team, or consultation 
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with decision-makers, and should be transparent. Two considerations are of critical importance 
when determining the size. The first is calculating and using absolute effects rather than using 
relative effects that can often be misleading. For instance, consider a risk ratio 0.84, or 16% 
relative reduction in hip fractures in older adults. If on the one hand, the baseline risk of hip 
fractures is 20/1000 over 1 year, the risk ratio 0.84 would translate to 3 fewer per 1000, which 
most would consider a small effect. On the other hand, if the baseline risk is 200/1000, many 
would consider that the resulting absolute reduction of 32 per 1000 is a moderate to large 
effect. The second is identifying the value of the outcome [16, 17]. Ideally, review authors 
identify the thresholds, and use them to rate the certainty of the evidence. The approach to 
choose a threshold (or range) can be either fully contextualised (based on consideration of all 
critical outcomes) or partially contextualised (based on the value of the individual outcome.) 
[20]. Whatever the thresholds, a decision needs to be made in order to write a statement using 
Table 1.  
 
When deciding on thresholds, review authors also need to be aware of the risk of 
misinterpreting a result with a wide confidence interval that includes ‘1’ (for relative effects) or 
‘0’ (for absolute effects) as ‘no effect’ or ‘no difference’ [22, 23]. For example, consider a mean 
difference for the effect of a treatment on quality of life is 1.5 (95% CI, -1.2 to 4.2) where an 
important effect is an increase of 1 on a scale of 1 to 10 (better), and the certainty of the 
evidence is low (due to imprecision and risk of bias). The point estimate is an increase of 1.5, 
and we would characterise the effect as important, likely moderate, but not ‘no effect’. Authors 
need to determine the size of the effect based on the effect estimate, not on the confidence 
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intervals. The width of the confidence interval is considered in the assessment of the certainty 
of the evidence (see Box 1). In this case, the certainty is low,we use the word ‘may’, and the 
final statement is, ‘the [treatment] may increase quality of life’. In contrast, if the effect was an 
increase of 0.3 (95% CI, -1.8 to 2.3), the effect could be categorised as ‘trivial, small 
unimportant or no effect’ because the effect estimate is less than our threshold for an 
important difference, and the final statement based on low certainty evidence would be ‘the 
[treatment] may have little to no effect on quality of life’.  
Box 1: Best estimate versus confidence intervals to determine effect size 
The statements communicate the size of the effect based on the point estimate in a meta-
analysis or on the summary estimate in a narrative synthesis instead of the confidence 
intervals. Confidence intervals represent the range in which a point estimate would fall if 
multiple experiments were conducted, or as the range of values either side of the estimate 
between which we can be 95% sure that the true value lies [22], and are calculated based on 
factors such as sample sizes and variance within or between studies. The calculation does not 
factor in the risk of bias of the studies; indirectness of the populations, interventions or 
outcomes; or, the risk of publication bias, which (if there were methods to do so) could widen 
the confidence intervals, making the calculated confidence intervals meaningless. However, 
when conducting a GRADE assessment authors consider the width of the confidence intervals 
and power of the analysis (i.e., imprecision) plus all of the other factors to determine the 
certainty of the evidence. Thus, the certainty around the point estimate varies depending on 
what domains demonstrate shortcomings and except for imprecision that certainty interval is 
not known [18, 19]. For this reason, when communicating an effect using statements, authors 
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should focus on the best estimate and on the certainty in that estimate which considers 
multiple factors.   
4.4. Use the statements in the text of a review and in Summary of Findings tables 
Authors can use these statements throughout a systematic review: in the abstract, plain 
language summary, results, discussion, and in evidence tables. Experience has shown that this 
approach to wording should not be an automated application, which could result in a list of 
monotonous statements. In GRADEpro (www.gradepro.org), the software programme to 
produce summary of findings tables, the size of effect and the certainty of evidence are used to 
automatically generate an editable statement (Figure 3).  
Figure 3: Screenshot of GRADEpro and automatic generation of informative statements based 
on size of effect and certainty of evidence 
 
Systematic reviews typically compare an intervention/test to a comparator. The statements in 
Table 1 do not explicitly state the comparator which may be acceptable when the comparator is 
standard care, a placebo, or no intervention, but when it is an alternative intervention, it’s 
important to include it. Using a hypothetical example, there is low certainty evidence that 
oseltamivir reduced the duration of symptoms by 2 days (95% CI, 0.5 to 3.6 days) when 
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compared to zanamivir, whereby 2 days was an important difference. The informative 
statement should be ‘oseltamivir may reduce the duration of symptoms more than zanamivir’. 
  
4.5 Borderline decisions and very low certainty of the evidence 
When applying the GRADE approach, authors may debate about the weight of each domain to 
determine the level of evidence. For example, in some cases, moderate certainty evidence may 
be due solely to imprecision, in other cases, it may be a combination of small concerns with 
imprecision, risk of bias and inconsistency. Despite these differences, authors must make a final 
decision about the level of evidence, and it is this level that determines the wording options 
available to use in that category. The GRADE approach to certainty of evidence, however, 
acknowledges that, despite the four categories of high, moderate, low and very low, certainty is 
a continuum [2]. Consequently, users may find that when deciding on the certainty they may 
have been on the threshold between categories, but ultimately had to choose a category, make 
a borderline decision, or characterise the certainty as being at a threshold. When choosing a 
statement in these instances, users could choose from the statements on either side of the 
border.  
  
We have also provided two options for a statement based on very low certainty of evidence: 
one option gives the direction of the effect, the other does not. Ratings are on a continuum and 
within the category of very low there may be situations when authors feel somewhat more 
compelled to express an effect (e.g., when the rating borders on low) and situations when they 
do not (e.g. the evidence is at the very bottom of the continuum of certainty). 
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4.6. Use of the statements in different review types 
The underlying principle considering size of effect and certainty of evidence (whether GRADE or 
another system with four levels) to write statements can likely be applied to any review type. In 
a test accuracy review with pooled sensitivity and specificity estimates, the absolute numbers 
of misidentified people (i.e., false negatives and positives) can be quantified as large, moderate, 
small, or trivial, depending on the consequences for patients. A review may find that a cytology 
test misses 20 more out of 1000 women with cervical cancer lesions than an HPV test - a small 
difference based on moderate certainty evidence. We could conclude that ‘when compared to 
HPV tests, cytology tests probably miss slightly more women with cervical lesions.’ In prognostic 
reviews, the statements could be written as ‘associations’. For example, for a moderately sized 
association of hip fractures with age and low certainty evidence, the statement would be ‘age 
may be associated with hip fractures’.  
 
5. Conclusions 
The informative statements to communicate results of systematic reviews should be used 
throughout the text of a systematic review, in the abstract, plain language summary, results, 
discussion, and in evidence tables. These statements can also be used in other tools and 
products that communicate the results of systematic reviews to decision makers, and in fact are 
already being used in health care guidelines to summarise the evidence and in patient versions 
of guidelines [27-29]. The list was also originally translated into Spanish, Norwegian, Italian, 
French and German [12], and future work will focus on these translations. 
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Thank you for volunteering to participate in our survey.
This survey is being conducted by a project group of the GRADE Working Group. The Hamilton
Integrated Research Ethics Board (HiREB) at McMaster University has waived the requirement for
individual consent. Your answers to this survey will be entered into a large database and will
remain confidential and anonymous (unless you provide your name so that we can contact you for
verbal feedback). This survey should take about 15-20 minutes to complete. 
We have been working on single statements to communicate the results of a systematic review.
Some example statements could be "taking vitamin C daily probably reduces your risk of catching a
cold" or "exercising 2 hours a week increases sleep duration slightly".  How we write
these statements are based on the importance/size of the effect (e.g., minimally important
difference, thresholds), and the certainty of the evidence.
In this survey, you will be shown 5 examples of the results of a systematic review and asked how
acceptable you think the single statement is. You can complete all 5 examples or stop any time. You
will also be given space to provide general comments about the statements at the end.
The survey is not a test at all. Rather, we would really like you to provide your opinion about
acceptable ways to communicate the results. 
If you have any questions about this survey, please contact Nancy Santesso at
santesna@mcmaster.ca
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APPENDIX 1: SURVEY
Background Information
1. What is your primary role related to systematic reviews and guidelines? (Select one that best represents
your role)
*
Methodologist who conducts systematic reviews
Clinical expert who conducts systematic reviews
Methodologist who has been involved in guideline development
Clinical expert who has been involved in guideline development
Methodologist not involved in systematic reviews or guidelines
Clinician not involved in systematic reviews or guidelines
Someone who reads systematic reviews
2. What is your education in epidemiology?
2
 Unacceptable Acceptable Ideal
a. Cognitive behaviour therapy may reduce depression slightly more than no therapy but
we are uncertain.
b. We are uncertain about the effect of cognitive behaviour therapy on depression. 
c. We are uncertain about whether cognitive behaviour therapy reduces depression more
than no therapy.
3. A systematic review compared the effects of cognitive behavioural
therapy versus a waiting list for military suffering from post-traumatic
stress disorder on depression. 
It found that cognitive behaviour therapy reduced depression by 8 points
more on a scale from 1-100 (95% confidence interval from 21 point
reduction to 12 point increase). This reduction is small but important. 
The evidence came from a meta-analysis with very few people (91) and
very serious concern that the studies were at high risk of bias because
of unclear randomisation and large loss to follow-up.
The conclusion about the effect of cognitive behaviour therapy could be
worded in the following three ways. Please indicate the acceptability of
each statement.
3
A systematic review compared the effects of co-enzyme Q10 versus placebo on blood pressure. A
summary of the findings is provided below. Note that the 1.62 mm/Hg reduction in blood pressure is a small
but important effect, but the evidence was assessed at 'very low quality/certainty'.
 Unacceptable Acceptable Ideal
a. Co-enzyme Q10 may reduce blood pressure slightly but we are uncertain.
b. We are uncertain about the effect of co-enzyme Q10 on blood pressure
c. We are uncertain about whether co-enzyme Q10 reduces blood pressure.
4. The conclusion about the effect of co-enzyme Q10 on blood pressure
could be worded in the following three ways. Please indicate the
acceptability of each statement.
4
Please see the results of a systematic review of probiotics compared to placebo on the incidence of
diarrhea in children.
 Unacceptable Acceptable Ideal
a. Probiotics may result in a large reduction in the incidence of diarrhea.
b. Probiotics likely result in a large reduction in the incidence of diarrhea.
c. Probiotics appear to result in a large reduction in the incidence of diarrhea.
d. The evidence suggests that probiotics result in a large reduction in the incidence of
diarrhea.
5. The authors of the review considered that the cut-off for a large effect
is RR 0.60. Please indicate the acceptability of the statements below. 
5
Please see the results of a systematic review on the number of hip fractures older people living in the
community experience when wearing hip protectors or not wearing hip protectors. Hip protectors are
cushioned undergarments that could deflect or cushion the impact of a fall.
 Unacceptable Acceptable Ideal
a. Hip protectors likely do not reduce hip fractures.
b. Hip protectors likely result in little to no difference in hip fractures.
c. Hip protectors probably do not reduce hip fractures.
d. Hip protectors probably result in little to no difference in hip fractures. 
6. The authors indicate that the effect found was less than their cut-off for
an effect. 
Please indicate the acceptability of the statements to communicate the
effects of hip protectors compared to no hip protectors on the number of
hip fractures.
6
Please see below the results for the effect of oral leukotriene receptor antagonists on daytime nasal
symptoms compared to placebo.
 Unacceptable Acceptable Ideal
a. Antagonists result in a small effect that may not be an important reduction in daytime
symptoms.
b. Antagonists result in a small possible unimportant reduction in daytime symptoms.
c. Antagonists do not result in an important reduction in daytime symptoms.
7. Please indicate the acceptability of the statements below to
communicate the effect of antagonists compared to placebo on daytime
nasal symptoms. 
Note: the authors considered the SMD and confidence interval a small
but not important effect.
7
8. Please take 5 minutes to review this list of options for statements to communicate results at various
levels of evidence and size of effect. If you'd like, please provide any general comments about the
statements below.
8
9. If you would like to provide additional comments verbally, please provide your contact information and we
will contact you.
9
Please provide comments if you'd like.
10. One last question: 
Do you agree in principle that conclusions should be based on the concepts of the importance/size of the
effect and the certainty of the evidence?
Yes
No
10
42.86% 48
11.61% 13
21.43% 24
10.71% 12
1.79% 2
0.00% 0
11.61% 13
Q1 What is your primary role related to systematic reviews and
guidelines? (Select one that best represents your role)
Answered: 112 Skipped: 0
TOTAL 112
Methodologist
who conducts...
Clinical
expert who...
Methodologist
who has been...
Clinical
expert who h...
Methodologist
not involved...
Clinician not
involved in...
Someone who
reads...
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
ANSWER CHOICES RESPONSES
Methodologist who conducts systematic reviews
Clinical expert who conducts systematic reviews
Methodologist who has been involved in guideline development
Clinical expert who has been involved in guideline development
Methodologist not involved in systematic reviews or guidelines
Clinician not involved in systematic reviews or guidelines
Someone who reads systematic reviews
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APPENDIX 2: Results of the survey of participants (not including GRADE project 
group members)
Q2 What is your education in epidemiology?
Answered: 87 Skipped: 25
# RESPONSES DATE
1 MSc epidemiology 4/12/2018 12:45 PM
2 Masters 4/9/2018 5:02 PM
3 Minimal; a class or two. 4/9/2018 9:39 AM
4 little, basic courses 4/9/2018 4:36 AM
5 MSc Doctor of Medicine [UK] 4/8/2018 8:02 PM
6 undergraduate level formal teaching as well as experience and knowledge gained in the
workplace.
4/8/2018 3:13 AM
7 MSc 4/6/2018 12:10 PM
8 no formal education 4/6/2018 5:11 AM
9 Masters 4/5/2018 3:26 PM
10 PhD 4/5/2018 12:19 PM
11 MSc Epidemiology 4/4/2018 8:08 AM
12 One post-graduate level paper 4/4/2018 4:43 AM
13 Post graduate master epidemiology. 4/4/2018 4:41 AM
14 PhD in statistical modelling 4/4/2018 3:31 AM
15 One year training in clinical epidemiology. Autodidact learning and teaching. Participating in
guideline development and implementation and in knowledge transfer.
4/3/2018 9:51 PM
16 phd 4/3/2018 9:11 AM
17 Master in Public Health 4/3/2018 8:40 AM
18 One semester Phd course. 4/3/2018 6:35 AM
19 None 4/3/2018 3:26 AM
20 As part of MPH degree 4/3/2018 3:25 AM
21 PhD 4/2/2018 11:28 PM
22 PhD 4/2/2018 2:50 PM
23 PhD epidemiology and biostats 4/2/2018 2:11 PM
24 MSc in Clinical Epidemiology 4/2/2018 7:35 AM
25 MSc 4/2/2018 2:41 AM
26 none 4/1/2018 7:14 AM
27 Diploma in evidence based healthcare 3/31/2018 10:30 PM
28 basic 3/31/2018 3:28 PM
29 MSc Clinical Epidemiology and Biostatistics 3/30/2018 5:34 PM
30 MSc Clinical Epidemiology 3/30/2018 11:55 AM
31 Masters in Public Health 3/29/2018 6:32 PM
32 Master of Public Health from Columbia University 3/29/2018 4:47 PM
33 Not sure how to answer this. Do you mean how many courses we had as master's and doctoral
students we have had? I have had training in classical epidemiology and clinical epidemiology.
3/29/2018 4:05 PM
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34 None. Masters in psychology. 3/29/2018 2:34 PM
35 15 hrs online course 3/29/2018 1:42 PM
36 No formal 3/29/2018 12:35 PM
37 PhD in nursing 3/29/2018 12:15 PM
38 Master in Public Health 3/29/2018 9:18 AM
39 Several courses as part of education. 3/29/2018 8:22 AM
40 Phd 3/29/2018 8:08 AM
41 I have a PhD in epidemiology and teach epidemiology for medical students. 3/29/2018 7:34 AM
42 PhD 3/29/2018 6:19 AM
43 during my PhD I became MSc in the epidemiology within a two year programma 3/29/2018 6:01 AM
44 Undergraduate level. I now work in communication of data. 3/29/2018 5:40 AM
45 None. 3/29/2018 2:04 AM
46 PhD, with over 10 years experience following 3/28/2018 9:59 PM
47 None formally. 20 years of experience with Cochrane 3/28/2018 7:03 PM
48 Master in clinical and translational science 3/28/2018 6:51 PM
49 MSc 3/28/2018 4:31 PM
50 msc 3/28/2018 4:12 PM
51 Training in Clinical epidemiology 450 h 3/28/2018 4:05 PM
52 Masters in Health Science specialising in critical appraisal of clinical practice guidelines 3/28/2018 1:29 PM
53 MSc Health Science. Post-grad training in population health. 3/28/2018 1:22 PM
54 PhD in public health 3/28/2018 11:44 AM
55 Master in Public Health 3/28/2018 8:53 AM
56 PhD 3/28/2018 8:26 AM
57 MSc and PhD in public health 3/28/2018 8:24 AM
58 none 3/28/2018 7:55 AM
59 PhD training; methodologist who conducts SR and participates in guidelines development, and has
clinical training
3/28/2018 7:47 AM
60 minimal, I am a physician specialist 3/28/2018 7:03 AM
61 No fomal education, but have undertaken postgraduate short courses in epidemiology, various
analysis techniques, systematic review and meta-analysis courses and have been working in an
epidemiological department for 20 years.
3/28/2018 6:57 AM
62 Masters and PhD in medical statistics 3/28/2018 6:23 AM
63 registration epidemiologist B 3/28/2018 4:06 AM
64 No degrees, just self-readings 3/27/2018 9:41 PM
65 I’m an M.D. 3/27/2018 8:58 PM
66 Masters degree 3/27/2018 4:48 PM
67 I have studied epidemiology in medical school 3/27/2018 4:47 PM
68 None 3/27/2018 4:30 PM
69 No education in epidemiology. My education is a BScN, and a MA in Psychology. 3/27/2018 2:49 PM
70 No formal education 3/27/2018 2:45 PM
71 It was a course in my MPH degree 3/27/2018 2:05 PM
72 MPH in Epidemiology 3/27/2018 1:48 PM
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73 masters in health studies 3/27/2018 12:47 PM
74 MSc 3/27/2018 11:26 AM
75 MD and MPH 3/27/2018 10:06 AM
76 No formal education. 3/27/2018 9:29 AM
77 Masters degree in public health 3/27/2018 8:20 AM
78 Masters level 3/27/2018 7:16 AM
79 MSc 3/27/2018 6:27 AM
80 Master in health economics 3/27/2018 3:42 AM
81 Master level 3/27/2018 3:10 AM
82 Medical school, and later personal education in relevant literature 3/26/2018 3:35 PM
83 None 3/26/2018 12:16 PM
84 None formal - work experience assisting with population research 3/26/2018 11:02 AM
85 medical sociologist, undergraduate pychology, PHD in Survey design, 12 years IQWiG. 3/26/2018 10:17 AM
86 no specific education 3/26/2018 10:10 AM
87 Limited 3/26/2018 9:51 AM
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Q3 A systematic review compared the effects of cognitive behavioural
therapy versus a waiting list for military suffering from post-traumatic
stress disorder on depression. It found that cognitive behaviour therapy
reduced depression by 8 points more on a scale from 1-100 (95%
confidence interval from 21 point reduction to 12 point increase). This
reduction is small but important. The evidence came from a meta-
analysis with very few people (91) and very serious concern that the
studies were at high risk of bias because of unclear randomisation and
large loss to follow-up.The conclusion about the effect of cognitive
behaviour therapy could be worded in the following three ways. Please
indicate the acceptability of each statement.
Answered: 91 Skipped: 21
36.67%
33
47.78%
43
15.56%
14
 
90
 
1.79
28.57%
26
51.65%
47
19.78%
18
 
91
 
1.91
14.29%
13
60.44%
55
25.27%
23
 
91
 
2.11
a. Cognitive
behaviour...
b. We are
uncertain ab...
c. We are
uncertain ab...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Cognitive behaviour therapy may reduce depression slightly
more than no therapy but we are uncertain.
b. We are uncertain about the effect of cognitive behaviour
therapy on depression. 
c. We are uncertain about whether cognitive behaviour
therapy reduces depression more than no therapy.
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Q4 The conclusion about the effect of co-enzyme Q10 on blood pressure
could be worded in the following three ways. Please indicate the
acceptability of each statement.
Answered: 90 Skipped: 22
46.07%
41
35.96%
32
17.98%
16
 
89
 
1.72
15.56%
14
56.67%
51
27.78%
25
 
90
 
2.12
16.67%
15
65.56%
59
17.78%
16
 
90
 
2.01
a. Co-enzyme
Q10 may redu...
b. We are
uncertain ab...
c. We are
uncertain ab...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Co-enzyme Q10 may reduce blood pressure slightly but we
are uncertain.
b. We are uncertain about the effect of co-enzyme Q10 on
blood pressure
c. We are uncertain about whether co-enzyme Q10 reduces
blood pressure.
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Q5 The authors of the review considered that the cut-off for a large effect
is RR 0.60. Please indicate the acceptability of the statements below. 
Answered: 91 Skipped: 21
10.11%
9
52.81%
47
37.08%
33
 
89
 
2.27
51.69%
46
39.33%
35
8.99%
8
 
89
 
1.57
50.00%
45
43.33%
39
6.67%
6
 
90
 
1.57
56.67%
51
31.11%
28
12.22%
11
 
90
 
1.56
a. Probiotics
may result i...
b. Probiotics
likely resul...
c. Probiotics
appear to...
d. The
evidence...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Probiotics may result in a large reduction in the incidence of
diarrhea.
b. Probiotics likely result in a large reduction in the incidence of
diarrhea.
c. Probiotics appear to result in a large reduction in the
incidence of diarrhea.
d. The evidence suggests that probiotics result in a large
reduction in the incidence of diarrhea.
7 / 17
How to communicate the results of systematic reviews using standard statements
Q6 The authors indicate that the effect found was less than their cut-off
for an effect. Please indicate the acceptability of the statements to
communicate the effects of hip protectors compared to no hip protectors
on the number of hip fractures.
Answered: 90 Skipped: 22
44.94%
40
40.45%
36
14.61%
13
 
89
 
1.70
23.33%
21
52.22%
47
24.44%
22
 
90
 
2.01
39.33%
35
47.19%
42
13.48%
12
 
89
 
1.74
21.35%
19
61.80%
55
16.85%
15
 
89
 
1.96
a. Hip
protectors...
b. Hip
protectors...
c. Hip
protectors...
d. Hip
protectors...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Hip protectors likely do not reduce hip fractures.
b. Hip protectors likely result in little to no difference in hip
fractures.
c. Hip protectors probably do not reduce hip fractures.
d. Hip protectors probably result in little to no difference in hip
fractures. 
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Q7 Please indicate the acceptability of the statements below to
communicate the effect of antagonists compared to placebo on daytime
nasal symptoms. Note: the authors considered the SMD and confidence
interval a small but not important effect.
Answered: 92 Skipped: 20
15.22%
14
42.39%
39
42.39%
39
 
92
 
2.27
49.45%
45
41.76%
38
8.79%
8
 
91
 
1.59
45.05%
41
38.46%
35
16.48%
15
 
91
 
1.71
a. Antagonists
result in a...
b. Antagonists
result in a...
c. Antagonists
do not resul...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Antagonists result in a small effect that may not be an
important reduction in daytime symptoms.
b. Antagonists result in a small possible unimportant reduction
in daytime symptoms.
c. Antagonists do not result in an important reduction in
daytime symptoms.
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Q8 Please take 5 minutes to review this list of options for statements to
communicate results at various levels of evidence and size of effect. If
you'd like, please provide any general comments about the statements
below.
Answered: 39 Skipped: 73
# RESPONSES DATE
1 Suggestion not important effect: small clinically not relevant reduction For example: High/not
important: results in a small clinically not relevant reduction
4/12/2018 3:05 PM
2 Question 5b in this survey was worded slightly different than below in a way that affected my
answer: "small possible unimportant" instead of "small possibly unimportant". I think the addition of
"possibly unimportant" is very helpful, but found it confusing the way it was worded in Question 5b.
I would add commas: "small, possibly unimportant,..." so the grouping of these words is clear. No
effect/high certainty: you can't say that something doesn't have effect. This is just wrong. Small
effect important/moderate certainty: I find the word slightly to be a bit confusing. Your mind has to
keep track of probably, and direction (reduces) and then amount. I would use "to some degree"
instead of "slightly". "probably" works much better for me than "likely", just because it is more
familiar and uses less brain power to combine the meaning of it with the other terms.
4/6/2018 5:32 AM
3 1. Regarding 'no effect', I think we need to differentiate clearly between two different situations
which seem to currently be treated as one and described as 'no effect': 1. where there is a tight
confidence interval around the null/line of no effect and the CI is completely within threshold limits
- in this case, we can say that there is little to no difference in the outcome. 2. where there is a
large confidence interval that crosses the null/line of no effect AND one or both important
threshold limits - in this case, I think it is misleading to state that there is "little or no difference" as
we cannot confirm or exclude an important difference. In this case, should we call this an
'uncertain' effect? Or that the effect is compatible with both little or no effect and an important
effect? It is more difficult to describe this in plain language, but I think it is important to convey the
uncertainty of the effect that exists in the second case. 2. Re the wording, "does not reduce/may
not reduce" etc, I think that given that there is always some uncertainty around the confidence
interval, that the word "not" is too strong. Prefer to state 'little or no difference". 3. The rest of the
statements outlined below are reasonable. This is a very useful project which will help ensure
correct interpretation in the results of Cochrane Reviews. Thank you!
4/5/2018 1:08 PM
4 None of the statements specify a comparitor. I think it would be useful to ensure that the
comparitor is always stated. For example, "Compared to Y, X results in a large reduction in
mortality" or "X results in a large reduction in mortality compared to Y". Some of the statements
include the word "evidence", while most do not. I think it would be useful to ensure that the word
evidence appears in these statements to make clear they are based on evidence rather than
opinion. For example, "The evidence shows that X results in a large reduction in mortality
compared to Y". It is not clear to me why statements may be phrased using "probably" or "likely"
and if there is a meaningful difference. I suggest picking one and discouraging use of the other.
Some of the statements allude to the concept of certainty of evidence (using words like "may" and
"appears"), while others make certaity explicit. I would favour making certainty explicit in all
phrases. For example "The evidence shows we can be reasonably certain that X results in a large
reduction in mortality compared to Y" or "The evidence shows we cannot be certain whether X
reduces mortality compared to Y". The statements do not consider the fact that, while a given
intervention may have little or no effect on average, it may have a large and important effect on a
small number of people. They also do not consider the potential harms of an intervention. There
may be interventions that are inexpensive and very safe, and which have little or no effect in most
people, but do have large and important effects in some people.
4/4/2018 4:31 AM
5 I like nuanced statements that provide precisions on which criteria are assessed (e.g. effect size,
importance) and allow for uncertainty to express (e.g. likely results in little or no difference)...
4/3/2018 10:30 PM
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6 When you think about importance of an effect size, do you consider whether a small effect could
be important if it applied across a whole population? I am asking because of a recent systematic
review where we and our clinician experts judged the size of the effect to be "little to no effet", but
others who read our review thought the size could be important if applied at a population level
4/3/2018 9:21 AM
7 HIGH - Instead consider "X slightly reduces mortality" (small effect (important)) - For small effect
(not important) -- "X does not result in an important reduction in mortality". The direction of the
observed effect is missing, and this seems important as a small effect may be meaningful to some
but not all. I prefer the statements in this category that include reference to the direction of effect.
MODERATE - I don't feel that "likely" and "probably" are good synonyms for MODERATE
evidence. Somehow I feel that "likely" is stronger and well suited here, but "probably" is less strong
and therefore not as well suited. Perhaps "likely results in" and "seems to result in" could work if
you want options? LOW - I feel that "appears to" belongs in the MODERATE category and not the
LOW category. I like "may" and "the evidence suggests" though. - for the "no effect" category, "X
may not reduce mortality" sounds like "X may or may not reduce mortality". I find it confusing and
may introduce ambiguity about being uncertain about the direction of the effect VERY LOW - I feel
that some qualifier as to where the uncertainty arises (i.e. low quality evidence) is needed. What
do you think about "X may reduce mortality, but the quality of evidence (or studies) is very low"? or
"X may reduce mortality, but we are very uncertain due to the low quality of the evidence (or
studies)"
4/2/2018 2:43 PM
8 Wordings are fine at HIGH or MODERATE certainty of the evidence, but problems arise at LOW
level of evidence. For example 'X may result in a large reduction in mortality' raises the question
whether the certainty of the evidence might be higher if 'large reduction' is replaced by 'reduction'
(clinically relevant reduction). In my view the conclusion should relate to what is considered a
clinically relevant effect, a clinically relevant reduction (or more general: the clinical decision
threshold) i.e. 'large' should not be part of the statement. The level of evidence relates to the
clinical decision threshold, usually the MID, and not to a 'larger' (or smaller) effect size. In principle
this is also true at HIGH or MODERATE certainty of the evidence, but because of the higher
certainty of the evidence, there is less of a problem. Similarly, I think that we should be careful
about conclusions on 'small (unimportant)' effects: all of our judgements should concern clinically
relevant effects, statements about 'unimportant' effects are confusing and may be misleading
4/2/2018 8:45 AM
9 Regarding the statements of 'No effect' (HIGH, MODERATE and LOW certainty): well, I have
learnt that you cannot keep the null hypothesis of no effect even if you cannot reject it. So you
should not say 'does not reduce mortality' or 'little or NO difference'. When the effect crosses the
line of 'no effect' - the results are uncertain and inconclusive. Very low certainty: I am not sure that
'may reduce mortality but we are uncertain' is a good idea. What about saying: "The results show a
reduction in mortality, but the certainty of the evidence for this is/ is assessed as very low." Also, I
think in general that the expression 'we are uncertain' sounds strange. Why are 'we' uncertain? It is
either the results (crossing line of no effect) or very low certainty of evidence in that case that
make us uncertain - so I think we should stress that it is the results/certainty of the evidence as
assessed that are uncertain - not we. We are not uncertain of that the results/evidence are
uncertain: "It is uncertain whether...", "the results are uncertain becuase of the possibility of either
a reduction or an increase in ..."
4/1/2018 1:59 PM
10 I think it is important to say x results in a large reduction...COMPARED to no intervention/placebo 3/31/2018 7:21 AM
11 Overall fewer words are preferred to communicate essential findings of quality and effect size 3/30/2018 12:23 PM
12 Prefer likely over probably. Wording "small possibly unimportant" is very confusing to lay readers
and is cognitively taxing Use of "but we are uncertain" negates "may reduce [...]; therefore no need
for "may reduce"
3/29/2018 9:25 AM
13 I am worried that the differences in wording between moderate/small important/small unimportant,
with differences in the structure of sentences, use or non-use of adjective quantifiers (eg small vs
slightly) and use or non-use of “important”, may lead to heterogenous interpretation between these
categories. Also, as always, there are issues with translating many of these quantifier terms.
3/29/2018 8:26 AM
14 As non-native speaker the difference between likely and probably is hard to grasp. In the previous
questions I felt that 'likely' is stronger than 'probably', but that might be personal. If you look these
words up in a Dutch-English dictionary the translation is largely the same. In the table I see they're
both used for Moderate CiE. Same for the difference between 'appears' and 'may', these words
have a different feel for me. 'Appears' is: it could be but we might be completely wrong'. 'May'
sounds more certain. This is really about language, and there may be differences between
countries/languages. High CiE and small not-important effect: by adding 'may not be' and 'possibly'
it seems that you have doubt about the importance of the effect, but as this is High CiE that is not
the case, no?
3/29/2018 7:07 AM
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15 using the word 'appears' by LOW evidence feels too strong for me, I prefer 'may'. 3/29/2018 6:15 AM
16 We are currently researching the communication of uncertainty in science, and use GRADE as an
example of good practice because of the way it separates the different sources of uncertainty
clearly - the calculated uncertainty around measurement is different from the quality of the
evidence. It is also vital that the magnitude of the effect and the quality of the data are not
confused (as they currently are in scales such as the IARC classifications of cancer risk, leading to
statements like 'bacon in same cancer risk bracket as cigarettes' and the genomic evidence scales
of 'pathogenic to benign'). I think it is important to give people as clear a view as possible of what
data is currently available. However, I appreciate that for a simple statement of conclusions, such
as in the preparation of guidelines, then it is important to give people a single sentence. I feel,
though, that that sentence should overtly retain the distinction between quality of evidence and
size of effect. So, in your examples below, I think they should be of the structure "There is
strong/weak evidence that X results in a large/small effect". I don't think that there is anything to be
gained in converting the phrases 'moderate evidence' to 'likely' - work on people's interpretation of
words used in common parlance suggest that they lead to much more variable interpretation than
keeping more precise language.
3/29/2018 5:58 AM
17 Effects should not be communicated solely in relative terms with words like „large“, „small“ etc.
Absolute effects should be added. In the probiotics example, the absolute effect is about 13 / 100.
Is that large?
3/29/2018 2:17 AM
18 The suggestion look good. I’m critical though with the choice of “slightly” for small but important
effect. In your graduation of statements, it sounds too close to small unimportant instead than in
between moderate an unimportant. My preference will be “small but important” difference. I have
my preference on the choices provided, but I can live with all but this one.
3/28/2018 7:24 PM
19 consistency is appreciated examples will be essential to develop consistency if these statements
are for a range of audiences this should be considered
3/28/2018 4:43 PM
20 Use appropriate comparisons for context (compared to Y); use plain language 3/28/2018 2:06 PM
21 A very helpful tool! 3/28/2018 1:44 PM
22 'Appears to' and 'evidence suggests' seem too strong for low quality evidence. With those
statements alone I would assume that there was certainty about the effects. Regarding the
inclusion of 'important' in the interpretation - will end-users know what is meant by important?
Could they use more elaboration about what is meant by an important difference? It is preferable
in my opinion to include the proposed/theoretical direction of effect even if there is no effect. e.g.,
'We are uncertain whether it reduces mortality' is preferable to 'we are uncertain about the effect
on mortality'. May just be personal preference.
3/28/2018 1:42 PM
23 word "appears" seems like a magical statement and not preferred in my opinion. it may be helpful
to provide illustrative examples with number to contextualize some of these wording options.
3/28/2018 12:11 PM
24 This makes sense and I agree in principle to the standardized wording. As long as you have a
critical appraisal checklist whereby you can grade the certainty of the findings of the study
according to very low, low, moderate and high then this system works; however not all checklists
grade the quality eg CASP
3/28/2018 9:47 AM
25 In general, the shortest text that fits the data is best (example: size of effect moderate: reduces
mortality, NOT results in a reduction in mortality) if an effect is certain, small, but definitely not
important, I would say: does not result in an important reduction in mortality, because clinical
relevance is more important than "methodological significance". I prefer "may" over likely or
probably; "suggest" is an acceptable alternative
3/28/2018 8:16 AM
26 I like the use of certain words to communicate certain levels of certainty; however, I am unsure
whether an end-user would distinguish between those words without having previously reviewed a
chart like the one below -- for example, I am uncertain whether most clinicians would immediately
pick up on the difference between may and likely. Also, for some reason, the word "appears" is not
preferable (it may be that it isn't as commonly used in science-writing in our field; appears
conjures up "magic" vs. some biologically plausible relationship) Lastly, there are some principals
of plain language writing that could be integrated into some of the sample statements that would
make them longer, but would also help with easier interpretation of the nuances. For example, I
would prefer a statement line: X may reduce mortality; however, it is likely that the reduction is not
clinically important. So, state the direction of the relationship first, and then follow with the
disclaimer about clinical significance.
3/28/2018 7:59 AM
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27 Having submitted reviewsz with this wording..most editorial boards have no knowledge of GRADe
cnsider this wording vague (comments received like "is it significant or not as probably and likely or
possibly is not wording we are used to see in results, please be more specific...." There is still a
long way before clinicians and peer reviewers, editors, guidelin emakers are familiar with GRADE
and its terminology
3/28/2018 7:16 AM
28 Generally I support the options aligned with the certainty levels (e.g. does, results in, will for
HIGH). It's not clear why some constructs are not included. For example there is no "X reduces"
for HIGH-Large, and no "X resutls in" for HIGH-Small. It seems that you could have options such
as "X reduces mortality substantially" and "X results in a slight reduction in mortality" for these. I
find some phrases too difficult to read and understand. Particularly "X results in a small possibly
unimportant effect". There are too many words next to each other!
3/28/2018 6:52 AM
29 - I'm not a native speaker, but 'appears' seems to suggest a little more than 'low' 3/28/2018 4:20 AM
30 I like all the statements for high and moderate certainty. I know we need to be cautious, but the
statements for low certainty are so vague that we run the risk that readers have no idea what we
mean. I’ve had feedback to this extent on recent Cochrane reviews.
3/27/2018 5:28 PM
31 I think it is a great idea to use such tool to standardize the way SR results are interpreted. 3/27/2018 4:52 PM
32 The double negative of some statements can be confusing. For example: X likely results in a small
effect that may not be an important reduction in mortality. I find for someone who is not well versed
in research, that can cause confusion. However, many of the other statements are clear.
3/27/2018 2:58 PM
33 I prefer the use of "probably" versus "likely" 3/27/2018 2:11 PM
34 Language preference is for: HIGH: "small possible unimportant effect in mortality" rather than
"does not results in an important reduction in mortality" and "results in little to no difference in
mortality" rather than "does not reduce mortality". MODERATE: "likely" rather than "probably".
LOW: "may result" rather than "appears to"
3/27/2018 9:51 AM
35 Statements need to be simple. "X results in a small effect that may not be an important reduction
in mortality" is too complicated a statement, for example - not to mention the equivalent statements
for lower QoE. General comments: - For a critical binary outcome, especially mortality, is there a
such a thing as an unimportant effect? How small would that be? - Why distinguish between an
unimportant effect and no effect? If this is to do with the problem of averages and individual
variance for continuous outcome measures (e.g. there is no important effect on average but some
patients may have a substantial benefit/Response), this should be made explicit.
3/27/2018 8:55 AM
36 I like to work with the standard phrasing as much as possible.It is great for abstracts and is as
good as any way to integrate the size and certainty of effect. There are two situations I find
troubling to work with: 1. Moderate quality evidence of moderate effect when you have
downgraded for imprecision. I always want to describe this in terms of greater uncertainty than
'probably' or even 'may'. I actually end up working something like: 'We found moderate quality
evidence that [intervention] reduces mortality by about 4% when compared with control, although
we do not have enough data from the studies to rule out there being little or no effect/potential
increase in risk of death (18% versus 14%; RR 0.73 (95% CI 0.34 to 1.2)' 2. Very low quality
evidence and large/moderate effect when you have a large amount of data from the analyses:
SMD 0.5 (0.2 to 0.8; 29 studies, 2300 participants). I don't always think that 'There is insufficient
evidence to determine the effects of' is really right here so end up with something like: 'Our
confidence in the moderate reduction in symptoms with intervention is very low due to bias and
variation between the results of the studies'.
3/27/2018 7:17 AM
37 1)X reduces mortality slightly - why not: reduction in mortality was small 2)"small possibly
unimportant" - could be confusing to people. It could be unclear to people what does it mean
"possibly unimportant" 3) When talking about "important reduction", some context is necessary.
What is important reduction? In the context of this information, it becomes apparent what is
important or unimportant reduction 4) "appears to result" has potential to be misleading. The
results should be described with more clarity. 5) There is not much difference in appears/may - the
wording is not very clear
3/26/2018 3:48 PM
38 The table is too complex to retain for mostly SR readers (i.e. non experts about SR production, like
primary care physicians...).
3/26/2018 12:42 PM
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39 Does "importance" always have to do with what is already known about the disease? Should every
reported outcome have a known level of importance? At a certain threshold, do all effect sizes
become "important" or can a moderate effect be "not important"? What exactly determines the
difference between small important/small not important? It would be helpful to see this clarified
with effect sizes.
3/26/2018 12:00 PM
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98.82% 84
1.18% 1
Q10 One last question: Do you agree in principle that conclusions should
be based on the concepts of the importance/size of the effect and the
certainty of the evidence?
Answered: 85 Skipped: 27
TOTAL 85
# PLEASE PROVIDE COMMENTS IF YOU'D LIKE. DATE
1 good idea! 4/6/2018 5:32 AM
2 I do agree with this statement, but I think there is a risk that importance and effect size may be
conflated into a single concept. To me, importance includes aspects such as quality of life,
possible adverse events, and patient preferences, while effect size is a necessarily specific
quantitative measure. I reiterate what I said above about the problem with excluding information
about potential harms (perhaps subsumed into the conceopt of importance), the fact that an
intervention that has little or no effect on average could actually have a large and important effect
in some people. I think it is also unwise to ignore practical issues such as the cost of an
intervention (or cost relative to an alternative) or how difficult it would be to implement the
intervention in the target population.
4/4/2018 4:31 AM
3 Totally agree with both concepts needing to be included in the conclusion -- I only feel that we may
need to explain WHY we are uncertain (i.e. low quality of evidence) as opposed to just saying
we're uncertain (for the VERY LOW quality category). Left unqualified "uncertainty" can stem from
many situations, so I think clearer to say because of low quality evidence.
4/2/2018 2:43 PM
4 Yes and NO: see my earlier comments, I think we should not be making statements on
'unimportant' (i.e. not clinically relevant/ not patient relevant) effects. Also there is a fundamental 
issue: the level of evidence relates to a clinically relevant effect (or similar clinical decision 
threshold) and not to a 'larger' (or smaller) effect. For example with a grading HIGH we might be 
very certain that a particular intervention is superior i.e. has a clinically relevant advantage as 
compared to the control, but how certain would we be that the advantage is 'large'? In theory one 
could define 'large' and use this as a threshold to judge e.g. imprecision, and come up with a 
grading for a 'large effect' (in my example the level of evidence could be HIGH for a clinically 
relevant effect, and MODERATE for a 'large effect'), but this would make the GRADE system 
much too complicated and confusing!
4/2/2018 8:45 AM
5 However, I must also say that as a methodologist and not a practitioner, it is often difficult to
assess the size/importance of an effect. We have been told by our reviewers to leave that
judgement to the practitioners.
4/1/2018 1:59 PM
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6 I think certainty of evidence is an improvement over the concept of quality of evidence. When it
comes to small effects, I am not sure I understand how we will decide between important and not
important.
3/30/2018 5:55 PM
7 results of this survey will be helpful to guideline developers. 3/30/2018 12:23 PM
8 What I find difficult is that the wording is about the importance/effect size and CiE, but what I (and
many colleagues) automatically do when interpreting the results is to take the CI into account
(wide CI make you less certain). I know this is not GRADE guidance, and I see that it makes sense
conceptually, but to me it's still counter-intuitive.
3/29/2018 7:07 AM
9 Yes, it's vital that guidelines and conclusions reflect both (and indeed the clinical importance rather
than the statistical significance of results). It does not mean that we have to wait for strong
evidence to be available before doing anything, but the quality of evidence should be taken into
account when making decisions.
3/29/2018 5:58 AM
10 There are other concepts that should be incorporated 3/28/2018 2:06 PM
11 A- methodologists' opinion should not matter when we are trying to standardise the readability for
end user, so I think surveying the likes of us is not going to get useful answers. B- A large chunk of
SR work and its use is happening in English as a second language people and countries (Think
Europe even). There is very little difference between the statements that I just saw from that
perspective (I have dealt directly with some decision makers and stakeholders in non English
countries). Standardising on our preferences and terms 'likely/ probably/ possibly' won't improve
readability for the end user if they are not native English speakers. C- I longed for an open ended
answer option for each question throughout, because I don't word a result statement without
referring to the whole PICO - personal preference.
3/28/2018 8:44 AM
12 Separating size of effect and certainty would be a helpful advance - similar to the separation of
QoE and recommendations - especially if judgements/decisions were to be made transparent.
3/27/2018 8:55 AM
13 But the context is very important, to explain to people why something is important or not important. 3/26/2018 3:48 PM
14 Sure. "(significance + grade of evidence) + (size + direction) of the effect " 3/26/2018 12:42 PM
15 Unless patients are not regularly involved in choosing / weighing endpoints for systematic reviews
the concept of importace may differ between clinicians / authors and patients
3/26/2018 10:20 AM
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52.63% 10
10.53% 2
31.58% 6
5.26% 1
0.00% 0
0.00% 0
0.00% 0
Q1 What is your primary role related to systematic reviews and
guidelines? (Select one that best represents your role)
Answered: 19 Skipped: 0
TOTAL 19
Methodologist
who conducts...
Clinical
expert who...
Methodologist
who has been...
Clinical
expert who h...
Methodologist
not involved...
Clinician not
involved in...
Someone who
reads...
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
ANSWER CHOICES RESPONSES
Methodologist who conducts systematic reviews
Clinical expert who conducts systematic reviews
Methodologist who has been involved in guideline development
Clinical expert who has been involved in guideline development
Methodologist not involved in systematic reviews or guidelines
Clinician not involved in systematic reviews or guidelines
Someone who reads systematic reviews
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Q2 What is your education in epidemiology?
Answered: 17 Skipped: 2
# RESPONSES DATE
1 PhD 4/3/2018 3:15 AM
2 Part of my undergraduate training. 'On-the-job' training undertaking systematic reviews and
teaching people how to undertake systematic reviews
4/2/2018 8:07 PM
3 Masters degree 3/30/2018 5:25 AM
4 None. 3/28/2018 12:56 AM
5 PhD in health research methods and MPH 3/27/2018 3:42 PM
6 Epidemiologist responsible for postgraduate teaching and supervision of epidemiology 3/27/2018 10:09 AM
7 nutritional epidemiology 3/27/2018 9:38 AM
8 equivalent to a masters 3/27/2018 8:55 AM
9 PhD(c) 3/26/2018 8:36 PM
10 I attended workshops 3/26/2018 3:33 PM
11 PhD Degree 3/26/2018 1:32 PM
12 PhD 3/26/2018 11:34 AM
13 No formal education in epidemiology. PhD in experimental medicine. 3/26/2018 10:08 AM
14 Master degree in Epidemiology 3/26/2018 9:45 AM
15 Mph- masters, epidemiology 3/26/2018 7:32 AM
16 Quantitative and qualitative meta-analysis methods. NMA training in WinBugs. 3/26/2018 6:58 AM
17 PhD 3/26/2018 6:37 AM
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Q4 A systematic review compared the effects of cognitive behavioural
therapy versus a waiting list for military suffering from post-traumatic
stress disorder on depression. It found that cognitive behaviour therapy
reduced depression by 8 points more on a scale from 1-100 (95%
confidence interval from 21 point reduction to 12 point increase). This
reduction is small but important. The evidence came from a meta-
analysis with very few people (91) and very serious concern that the
studies were at high risk of bias because of unclear randomisation and
large loss to follow-up.The conclusion about the effect of cognitive
behaviour therapy could be worded in the following three ways. Please
indicate the acceptability of each statement.
Answered: 19 Skipped: 0
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7
36.84%
7
26.32%
5
 
19
 
1.89
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5
36.84%
7
36.84%
7
 
19
 
2.11
# PLEASE PROVIDE COMMENTS IF YOU HAVE ANY. DATE
1 Difference between b and c depends if it is in the context of an SoF-table. If yes, then I prefer b. if
not, I prefer c.
4/3/2018 3:19 AM
2 So this is a low certainty of effect situation which is what makes the example hard. I prefer to give
a hint to what the effect estimate is even with low certainty evidence.
3/27/2018 3:45 PM
3 I assume that the certainty in this example is very low (downgraded twice for risk of bias and once
for imprecision). While I appreciate the logic of not indicating any effect direction within the
conclusion, I think this is problematic for many/most(?) reviews. In my areas of research, most
assessments come out as very low with the occasional low.
3/27/2018 10:27 AM
a. Cognitive
behaviour...
b. We are
uncertain ab...
c. We are
uncertain ab...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Cognitive behaviour therapy may reduce depression slightly
more than no therapy but we are uncertain.
b. We are uncertain about the effect of cognitive behaviour
therapy on depression. 
c. We are uncertain about whether cognitive behaviour
therapy reduces depression more than no therapy.
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4 Even in case of very low certainty of the evidence I think you should state an effect was observed. 3/27/2018 9:44 AM
5 I would find the following acceptable: Cognitive behaviour therapy may reduce depression slightly
more than no therapy but we are very uncertain.
3/26/2018 8:38 PM
6 a. The uncertainty is reflected in the "may". The "but we are uncertain" part is redundant and may
seem contradictory and result in confusion. It does depend, however, on how much uncertainty
you believe is expressed in the word "may" c. Acceptable but too many words. Readers may
spend a lot of time trying to make sure they understand the statement correctly, and when they
finally do they realize that there is no answer to the question
3/26/2018 1:38 PM
7 I would have rated this as very low certainty and would rather say "it is unclear whether
cognitive..."
3/26/2018 10:20 AM
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Q5 The conclusion about the effect of co-enzyme Q10 on blood pressure
could be worded in the following three ways. Please indicate the
acceptability of each statement.
Answered: 19 Skipped: 0
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# PLEASE PROVIDE COMMENTS IF YOU HAVE ANY. DATE
1 This example also adds the issue of small effect and the implication from a population point of
view. so you may want to say "reduces individual's BP"
3/27/2018 3:48 PM
2 the rationale is the same as I stated before 3/27/2018 9:45 AM
3 I would find the following acceptable: Co-enzyme Q10 may reduce blood pressure slightly but we
are very uncertain.
3/26/2018 8:39 PM
4 is it 1.6 the difference between both arms or the absolute effect? I assume the difference is meant,
but very misleading in the SOF! Lower by xxx more is quite confusing... In all the statements
compared to placebo is missing
3/26/2018 3:45 PM
5 a. Same comment as previous question For b vs c, it's a matter of what you are certain or
uncertain of. I would say it makes little difference when the certainty is very low, but it may be
more important when you have moderate certainty due to imprecision, and you have to
communicate whether you have moderate certainty of an effect or of a lack of effect
3/26/2018 1:46 PM
6 I would use may if low certainty. Again would rather use unclear, and in that case c) 3/26/2018 10:22 AM
a. Co-enzyme
Q10 may redu...
b. We are
uncertain ab...
c. We are
uncertain ab...
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Co-enzyme Q10 may reduce blood pressure slightly but we
are uncertain.
b. We are uncertain about the effect of co-enzyme Q10 on
blood pressure
c. We are uncertain about whether co-enzyme Q10 reduces
blood pressure.
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Q6 The authors of the review considered that the cut-off for a large effect
is RR 0.60. Please indicate the acceptability of the statements below. 
Answered: 19 Skipped: 0
15.79%
3
36.84%
7
47.37%
9
 
19
 
2.32
66.67%
12
22.22%
4
11.11%
2
 
18
 
1.44
42.11%
8
52.63%
10
5.26%
1
 
19
 
1.63
42.11%
8
36.84%
7
21.05%
4
 
19
 
1.79
# PLEASE PROVIDE COMMENTS IF YOU HAVE ANY. DATE
1 b&c: related to moderate QoE to me. d: I wouldn't move into this direction, the word 'suggest' might
be confused with terminology for weak recs.
4/3/2018 3:30 AM
2 It will be very concerning if we ignore the certainty in the statements. I prefer to explicitly state that
we are not certain in addition to the "may" or "appear to"
3/27/2018 3:51 PM
3 Given there is low certainty, that should ideally be communicated within the conclusion. The word
'suggests' seems to communicate that best but all seem acceptable.
3/27/2018 10:36 AM
4 b is unacceptable: "likely" is in contradiction with low QoE. 3/27/2018 9:48 AM
5 The wording needs to include some reflection that the evidence is of low certainty. 3/26/2018 8:46 PM
6 as an adjunct to antibiotics compared to placebo... 3/26/2018 3:49 PM
7 Maybe it's for simplicity for this survey but I wonder if the guidance should be that the narrative
statements regarding magnitude should be made based on the absolute effects. May, appear, and
suggest all communicate considerable uncertainty to me, which matches the low certainty. Likely
sounds too strong.
3/26/2018 1:51 PM
a. Probiotics
may result i...
b. Probiotics
likely resul...
c. Probiotics
appear to...
d. The
evidence...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Probiotics may result in a large reduction in the incidence of
diarrhea.
b. Probiotics likely result in a large reduction in the incidence of
diarrhea.
c. Probiotics appear to result in a large reduction in the
incidence of diarrhea.
d. The evidence suggests that probiotics result in a large
reduction in the incidence of diarrhea.
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8 Option d could be confused with a weak recommendation 3/26/2018 1:48 PM
9 I think the word large should be omitted from all statements, since 0.6 is outside the 95% ci. 3/26/2018 7:39 AM
8 / 15
GRADE project group: Communicating the results of systematic reviews using standard statements
Q7 The authors indicate that the effect found was less than their cut-off
for an effect. Please indicate the acceptability of the statements to
communicate the effects of hip protectors compared to no hip protectors
on the number of hip fractures.
Answered: 17 Skipped: 2
58.82%
10
29.41%
5
11.76%
2
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1.53
25.00%
4
56.25%
9
18.75%
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1.94
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6
17.65%
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1.71
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2
29.41%
5
58.82%
10
 
17
 
2.47
# PLEASE PROVIDE COMMENTS IF YOU HAVE ANY. DATE
1 b&d: ideal (if you feel probably and likely are interchangeable, I do) a&c: I don't like 'do not', 'little
to no difference' solves a lot of problems.
4/3/2018 3:38 AM
2 The use of likely is important because it reflects the certainty 3/27/2018 3:52 PM
3 The clinical question is about reducing hip fracture risk so communicating the take-home message
in relation to that makes sense. The 'little to no difference' is obviously technically correct but less
intuitive and understandable.
3/27/2018 10:44 AM
4 b/d reflects there was an effect although (very) small. Note: In Dutch language it is hard to know
what is the difference between likely and probably.
3/27/2018 9:55 AM
a. Hip
protectors...
b. Hip
protectors...
c. Hip
protectors...
d. Hip
protectors...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Hip protectors likely do not reduce hip fractures.
b. Hip protectors likely result in little to no difference in hip
fractures.
c. Hip protectors probably do not reduce hip fractures.
d. Hip protectors probably result in little to no difference in hip
fractures. 
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5 "The authors indicate that the effect found was less than their cut-off for an effect." - do you mean
less than cut off for an important effect? Assuming that the CI interval excludes an important
difference, then b or d is acceptable. I feel strongly that we should never ever rate our certainty
that there is 'no effect' -- there will always be infinitely too much imprecision.
3/26/2018 8:52 PM
6 This one is hard. Some things to consider - The RR seems to be for an increase in hip fractures
(there are more fractures in the HP group), so why are all the statements about HP reducing the
risk? To me this is about providing guidance with regards to how to frame the statement: based on
what we expected to see (in this case, HP and their likelihood of reducing fractures), or what we
saw (in this case, HP increased fractures). - If the former, should the statement about the presence
of an effect versus the presence of no effect be based on/ modified by what we expected to see? -
I said this before, but it may be important to be explicit about whether the statement is based on
the point estimate, the CI, or when is which. In this example it you use the CI (no effect vs little to
no effect) while in the others you used the point estimate+ CI (effect vs no effect), even if you had
less certainty.
3/26/2018 2:04 PM
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Q8 Please indicate the acceptability of the statements below to
communicate the effect of antagonists compared to placebo on daytime
nasal symptoms. Note: the authors considered the SMD and confidence
interval a small but not important effect.
Answered: 17 Skipped: 2
11.76%
2
47.06%
8
41.18%
7
 
17
 
2.29
35.29%
6
58.82%
10
5.88%
1
 
17
 
1.71
47.06%
8
23.53%
4
29.41%
5
 
17
 
1.82
# PLEASE PROVIDE COMMENTS IF YOU HAVE ANY. DATE
1 b: I would not try to incorporate any uncertainty about the clinical threshold within this standard
statement, I feel cognitively that really is too much, and too confusing. We set a treshold (and that
is of course always uncertain and highly depending on a lot of factors, but nevertheless it
complicates these statements if we try to incorporate this). I would reserve the word 'possibly' as
one of the option for expressing uncertainty in case of QoE LOW.
4/3/2018 3:51 AM
2 If the reduction is not of any clinical importance, mentioning it within the conclusion is misleading
and muddies the water. The wording "may not be an important reduction" and "possible
unimportant reduction" are a bit strange. Surely, there is little uncertainty in the decision about
whether these are or are not important (unless it is genuinely on the borderline of clinical
importance)?
3/27/2018 10:57 AM
3 b is more concise than a. Thatis why I prefer this one. c lacks nuance. 3/27/2018 9:57 AM
a. Antagonists
result in a...
b. Antagonists
result in a...
c. Antagonists
do not resul...
0 1 2 3 4 5 6 7 8 9 10
 UNACCEPTABLE ACCEPTABLE IDEAL TOTAL WEIGHTED
AVERAGE
a. Antagonists result in a small effect that may not be an
important reduction in daytime symptoms.
b. Antagonists result in a small possible unimportant reduction
in daytime symptoms.
c. Antagonists do not result in an important reduction in
daytime symptoms.
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4 To say with any certainty that the effect is unimportant, then we need to also know the distribution
of the effect. Is it normal? For example, are there some people in whom antagonists confer a large
important effect and in others no effect? Have a look at how we took into consideration the
distribution in this guideline: https://www.bmj.com/content/357/bmj.j1982 Ideal would be:
Antagonists result in a small reduction in daytime symptoms that most people would probably not
consider important. We also need to have a high degree of certainty in the MID to say anything
about importance, don't we? We also need to be certain (or at least make the assumption) that
most people have similar MIDs, or at least that most people would not consider it important. I'm not
sure that's the case here... So I think really what we are rating is that there is a difference.
Probably better to say that there is a difference and leave it at that, unless you can provide more
information as above.
3/26/2018 9:03 PM
5 a. OK but too wordy and confusing b. OK but reads weird to me. Maybe "small but unimportant",
"small but not important" c. Does not present the full picture in which you have high certainty. It
could mean that there is a small and unimportant effect or that there is no evidence of effect (not
statistically significant)
3/26/2018 2:07 PM
6 I prefer c) but important to clearly define the chosen threshold for an important effect 3/26/2018 10:32 AM
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Q9 Please take 5 minutes to review this list of options for statements to
communicate results at various levels of evidence and size of effect.
Please add any general comments about the statements below.
Answered: 12 Skipped: 7
# RESPONSES DATE
1 Some of the statements are very clumsy with poor grammar, hard to understand what they mean
without reading them several times
4/3/2018 9:41 AM
2 In a lot of situations 'little to no difference' solves a lot of issues because panelist in general seem
to have problems when we say there is no effect when we the point estimate suggest there is (but
our judgements say there is a small effect that is rated as not important to patients). Major issue is
using standardized statements in the context of a SoF. Within the context of a SoF: my preference
is to keep them as brief as possible (but giving just enough information readers are able to
understand (by for example making the assumption that the comparison is clear form the table: so
no need to repeat in the statement), and to be able to present them in user friendly format.) As
soon as people decide to go outside the SoF readability usually really decreases, because they
often feel the urge to incorporate all the info that is in a SoF:) Last point: I feel this colum in SoF is
really crucial, because - if we like it or not - most end-users (naive or not) need help interpreting
what the SoF says per outcome. People also use the word 'possibly' indicating LOW quality
evidence. Might be another option. I would leave out the option 'X probably may result in a small
possibly unimportant effect'. Very simply put: I currently think of these statments as expressing 1)
the uncertainty (is/probably is/possibly is/uncertain) and 2) judgement about the magnitude (call it
clinically relevance or importance to patient) preferably based on cutt-of value. I used the options
below quiet a lot (and we translated them into Dutch), and in almost all instances they work for me.
4/3/2018 4:19 AM
3 Think the 'small possibly unimportant' statement is confusing and prefer the 'small effect that may
not be an important reduction'. The 'does not result in an important reduction' seems too blunt.
The 'moderate' category doesn't have an adjective to it whereas the large and small categories do
Prefer 'likely' as opposed to 'probably' Why in the Low certainty of evidence section is there an
option of 'The evidence suggests' when this is not in the other sections? Very low section - prefer
the 2nd and 3rd statements as opposed to the 1st
4/2/2018 9:14 PM
4 I tend to prefer the terms probably for moderate certainty and may for low certainty. Likely and
appears also seem to be acceptable synonyms. I would tend not to use may for very low certainty
evidence.
3/30/2018 5:49 AM
5 Did you consider adding the following to the list We are certain, x results in large reduction We are
mod certain, x results in large effect We are uncertain, x results in large effect
3/27/2018 4:01 PM
6 For small not important effect, I prefer the bottom of the three suggested options. I also generally
prefer the top option for no effect. For moderate certainty and a small effect (not important), I think
it would be better to replace "may not be an important reduction" with "is not an important
reduction". The wording of "small possibly unimportant effect" could be replaced by "small but
unimportant effect".
3/27/2018 11:12 AM
7 Wordings are generally quite acceptable. But in case of very low certainty I would like to suggest
to add "very" to uncertain in the last two sentences.
3/27/2018 10:04 AM
8 Making mention of a magnitude of effect requires a values judgement. One that can be empirically
measured in a population. If the authors use their own judgement (always extremely dubious),
then they need to be explicit. I don't think that we can ever have high or moderate certainty that an
effect is large or small without also having certainty that all or almost all people would weigh the
magnitude in effect similarly. There is probably a huge amount a variability between people in how
much value they place on different effect sizes. At least that is my experience. So, if we include a
magnitude of effect in the certainty ratings, we need to incorporate our certainty in the typical and
distribution of values and preferences of those who the evidence applies to.
3/26/2018 9:11 PM
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9 High certainty: small effect (not important): x results in a small possibly unimportant sounds very
confusing for the reader, I suggest to remove this option same is true for moderate certainty, even
more confusing: probably small possibly unimportant. What does this mean?? As I am not a native
speaker: Is probably and likely exactly the same in English? low certainty: is may and appear
exactly the same? For me, may sounds more convincing...I prefer slightly over may and appears
for low certainty. For no effect, low certainty I prefer the sentences with the "little to no difference"
very low certainty: I prefer the sentences starting with: we are uncertain
3/26/2018 4:02 PM
10 It is not clear to me whether "The evidence suggests...." is a necessary option in case of low
evidenice. It is not used in other scenarios at all. I could imagine that this makes a difference in
terms of commuicating results and/or conclusions. The statement "the evidence suggests..." is
quite unpersonal. This might also imply that evidence suggests XYZ, but we (the authors) think
that ABC. All other statements are more straight forward in this sense, in my opinion.
3/26/2018 10:00 AM
11 This is a good start that needs some discussion going forward. 3/26/2018 7:46 AM
12 Although stronger statements are reasonable when certainty is higher, the imprecision is already
factored in. So the effect size needs to be considered in terms of absolute effects.
3/26/2018 7:07 AM
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94.12% 16
5.88% 1
Q10 One last question: Do you agree in principle that conclusions should
be based on the concepts of the importance/size of the effect and the
certainty of the evidence?
Answered: 17 Skipped: 2
TOTAL 17
# PLEASE PROVIDE COMMENTS IF YOU'D LIKE. DATE
1 Also have to consider impact of adverse effects and safety 4/3/2018 9:41 AM
2 I fully agree! And this is really a great help formulating conclusion /evidence statements. Thanks
for this great work.
4/3/2018 4:19 AM
3 This is extremely important to highlight . The certainty of the evidence is what usually gets lost 3/27/2018 4:01 PM
4 The importance/size of the effect is crucial and often not given adequate consideration. 3/27/2018 11:12 AM
5 The effect size is very important. It will help you in balancing benefits and harms (in the EtD
framework)
3/27/2018 10:04 AM
6 I don't think we're there yet. 3/26/2018 9:11 PM
7 Yes, but these should always be in relation to each other, ie the certainty rating should be made in
relation to the defined range of importance/size of effect.
3/26/2018 10:36 AM
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APPENDIX 3: Examples of using informative statements 
 
Example 1 
Review: Gibson  M et al. Welfare-to-work interventions and their effects on the mental and physical 
health of lone parents and their children. Cochrane Database of Systematic Reviews 2018, 
Issue 2. Art. No.: CD009820.  
Intervention: Welfare-to-work interventions to improve employment and income in lone parents 
compared to usual care 
Outcome: Maternal health/Number of mothers reporting poor health 
Risk Ratio: 0.85 (95% CI, 0.54 to 1.36) 
Absolute effects: 30 per 1000 fewer mothers reporting poor health (from 92 fewer to 73 more) 
 
If the authors set a threshold of 40 fewer mothers reporting poor health as a small 
important effect, the point estimate is identified as a trivial, small unimportant effect or no 
effect.  
Certainty of evidence: Moderate certainty (rated down once for imprecision due to wide confidence intervals 
including a small important effect) 
 
Options for informative statements 
Welfare-to-work interventions probably results in little to no effect on maternal health 
Welfare-to-work interventions likely results in little to no effect on maternal health 
Welfare-to-work interventions probably does not improve maternal health 
Welfare-to-work interventions likely does not improve maternal health 
 
 
Example 2 
 
Note: The authors set a threshold of a small important effect at 5 fewer people with URTI, therefore the effect is a small 
important effect. Evidence is low certainty due to some concern with imprecision/inconsistency and risk of bias. 
 
Options for informative statements 
Probiotics may reduce the number of people with an URTI slightly 
The evidence suggests probiotics reduces the number of people with an URTI slightly 
Probiotics may result in a slight reduction in URTIs 
The evidence suggests probiotics results in a slight reduction in URTIs 
